CN1127652A - Oral liquid for restoration of cancer - Google Patents

Oral liquid for restoration of cancer Download PDF

Info

Publication number
CN1127652A
CN1127652A CN 95111175 CN95111175A CN1127652A CN 1127652 A CN1127652 A CN 1127652A CN 95111175 CN95111175 CN 95111175 CN 95111175 A CN95111175 A CN 95111175A CN 1127652 A CN1127652 A CN 1127652A
Authority
CN
China
Prior art keywords
radix
fructus
cancer
parched
brown
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 95111175
Other languages
Chinese (zh)
Inventor
陈尔东
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 95111175 priority Critical patent/CN1127652A/en
Publication of CN1127652A publication Critical patent/CN1127652A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The recovering oral liquid for cancer with distinct curative effect and low cost is made up from 14 Chinese-medicinal materials such as pilose asiabell root, astraglus root, Chinese angelica root, wolfberry fruit, white atractylodes rhizome, etc. through slicing, decoction, filtering, concentration and filling.

Description

Oral liquid for restoration of cancer
The present invention relates to a kind of prescription of oral liquid, particularly a kind of oral liquid that is suitable for cancer patient's rehabilitation.
Cancer is human formidable enemy.The main means of treatment cancer are operation, chemotherapy, radiotherapy etc. at present.Must cause again simultaneously in treatment that a large amount of normal cells are killed and wounded in the body, especially bone marrow hematogenesis further descends in cell and body's immunity, thereby influences the normal tissue cell growth, has delayed wound healing, or bring out severe infection and hemorrhage, or impel the propagation and the diffusion of residual cancer cell.Up to the present, treatment of cancer does not also have any specific drug, and some effect of anticancer drugs is poor, and side effect is big, because these medicines are not all from improving cancer patient's immunocompetence and animation, curative effect does not show.Because the generation of cancer, development or recur one of of paramount importance factor are body (master contracts) immunologic function degression, so the human body immunity improving function can suppress the growth of tumour cell breeding, so as to reaching therapeutic purposes.The biological preparation of relevant human body immunity improving function is a lot of both at home and abroad at present, but its preparation is numerous and diverse, costs an arm and a leg, and the shakiness of tiring, and is difficult to promote the use of.In addition, aspect cancer patient's postoperative rehabilitation, how by the slow rehabilitation of nutraceutical, also have nothing good rehabilitation product or oral liquid.
Purpose of the present invention is exactly in order to address the above problem, and proposes the oral liquid for restoration of cancer that a kind of curative effect shows, rehabilitation efficacy is good.
Technical solution of the present invention:
A kind of oral liquid for restoration of cancer, it is characterized in that it by Radix codonopsis pilosulae (Radix Codonopsis), the Radix Astragali, Radix Angelicae Sinensis, Fructus Lycii, the Rhizoma Atractylodis Macrocephalae, Poria, Radix Glycyrrhizae, Fructus Ligustri Lucidi, Endothelium Corneum Gigeriae Galli, Cornu Cervi tablet, Fructus Crataegi (parched to brown), Massa Medicata Fermentata (parched to brown), Fructus Jujubae, interior osmanthus through section, decoction, filter and remove residue, concentrate, fill makes, the percentage by weight of its each composition is:
The 5-10% of Radix codonopsis pilosulae (Radix Codonopsis)
Radix Astragali 15-20%
Radix Angelicae Sinensis 5-10%
Fructus Lycii 5-10%
Rhizoma Atractylodis Macrocephalae 5-10%
Poria 5-10%
Radix Glycyrrhizae 3-5%
Fructus Ligustri Lucidi 5-10%
Endothelium Corneum Gigeriae Galli 5-10%
Cornu Cervi tablet 5-10%
Fructus Crataegi (parched to brown) 5-10%
Massa Medicata Fermentata (parched to brown) 5-10%
Fructus Jujubae 5-10%
Cortex Cinnamomi 3-5%
The present invention uses Chinese and western medicine theory, accumulation many decades clinical practice experience is selected the rare Chinese medicine material for use, has developed oral liquid for restoration of cancer of the present invention, it has supporing yang setting upright, support Tianjin hemopoietic, the kidney invigorating and essence nourishing, functions such as replenishing QI to invigorate the spleen, and can regulate gastrointestinal function, appetite stimulator improves sleep, promotes the wound rehabilitation.Can also improve cancer patient's immunologic function, suppress and kill residual cancer cell, and have protection bone marrow concurrently, improve red, leukocytic effect, promote the recovery of deficient syndrome patient's physiological function after cancer and the various operation.Oral liquid of the present invention can improve cancer patient's life quality, prolongs the existence time limit, and does not have any toxicity, and cost is low, and curative effect is very remarkable, but large tracts of land promotes the popularization use.
Embodiment (with 10 in a box, every 20ml is an example):
Get Radix codonopsis pilosulae's 30 grams, the Radix Astragali 60 grams, Radix Angelicae Sinensis 30 grams, Fructus Lycii 30 grams, the Rhizoma Atractylodis Macrocephalae 30 grams, Poria 30 grams, Radix Glycyrrhizae 15 grams, Fructus Ligustri Lucidi 30 grams, Endothelium Corneum Gigeriae Galli 30 grams, Cornu Cervi tablet 30 grams, Fructus Crataegi (parched to brown) 30 grams, Massa Medicata Fermentata (parched to brown) 30 grams, 6 pieces in Fructus Jujubae, Cortex Cinnamomi 15 grams mix them after selection, section, decoct for three times then, temperature is 80-100 ℃, and each decocting time is 30 minutes.The each decoction left and taken decoction liquor, and filtering sediment decocts once more.At last three decoction liquor are mixed, and filter, remove slag, concentrate, last filling and sealing, autoclaving promptly get oral liquid of the present invention.
Motherland's medical science thinks that the kidney being the origin of congenital constitution, the spleen being the foundation of acquired constitution. Of the present invention joining RADIX CODONOPSIS PILOSULAE from Shanxi of China in the side, state in vain, Yun Ling, Radix Glycyrrhizae be the master that Sijunzi Tang consists of supporing yang tonifying Qi The side has the effect that replenishes qi to invigorate the spleen. The compatibility of the Radix Astragali, angelica danggui buxue decoction can Benefit gas lift blood. The fruit of Chinese wolfberry, the fruit of glossy privet, sliced CORNUS CERVI, Chinese cassia tree are all trained the tonifying kidney-yin kidney yang. Chicken Interior gold, charred FRUCTUS CRATAEGI, stir-baked MASSA FERMENTATA MEDICI-NALIS and in help fortune, improve a poor appetite. The date coordinating the drug actions of a prescription. For Assistant makes it agent. Full side's tonifying spleen of the present invention is to support the foundation of acquired constitution. Kidney-nourishing is with strong the congenital foundation, But benefit gas enhanced machine body immunity function, blood-nourishing blood-generating can alleviate the Radiotherapy chemotherapy reaction, improves Body physique more is aided with the product for the treatment of for relieving indigestion and constipation. Both can help digest, food is absorbed, It is little to change production of sperm, flourish foster whole body, and can promote drug absorption, reduce the greasy spleen that blocks up of temperature compensation product Disadvantage, make it to mend and oiliness, reach and improve the health, set upright and drive evil dual function. Show that through the many cases clinical testing oral liquid of the present invention is to improving cancer patient's life quality, Prolong the existence time limit and have good effect.

Claims (1)

1, a kind of oral liquid for restoration of cancer, it is characterized in that it by Radix codonopsis pilosulae (Radix Codonopsis), the Radix Astragali, Radix Angelicae Sinensis, Fructus Lycii, the Rhizoma Atractylodis Macrocephalae, Poria, Radix Glycyrrhizae, Fructus Ligustri Lucidi, Endothelium Corneum Gigeriae Galli, Cornu Cervi tablet, Fructus Crataegi (parched to brown), Massa Medicata Fermentata (parched to brown), Fructus Jujubae, interior osmanthus through section, decoction, filter and remove residue, concentrate, fill makes, the percentage by weight of its each composition is:
The 5-10% of Radix codonopsis pilosulae (Radix Codonopsis)
Radix Astragali 15-20%
Radix Angelicae Sinensis 5-10%
Fructus Lycii 5-10%
Rhizoma Atractylodis Macrocephalae 5-10%
Poria 5-10%
Radix Glycyrrhizae 3-5%
Fructus Ligustri Lucidi 5-10%
Endothelium Corneum Gigeriae Galli 5-10%
Cornu Cervi tablet 5-10%
Fructus Crataegi (parched to brown) 5-10%
Massa Medicata Fermentata (parched to brown) 5-10%
Fructus Jujubae 5-10%
Cortex Cinnamomi 3-5%
CN 95111175 1995-08-28 1995-08-28 Oral liquid for restoration of cancer Pending CN1127652A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 95111175 CN1127652A (en) 1995-08-28 1995-08-28 Oral liquid for restoration of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 95111175 CN1127652A (en) 1995-08-28 1995-08-28 Oral liquid for restoration of cancer

Publications (1)

Publication Number Publication Date
CN1127652A true CN1127652A (en) 1996-07-31

Family

ID=5078487

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 95111175 Pending CN1127652A (en) 1995-08-28 1995-08-28 Oral liquid for restoration of cancer

Country Status (1)

Country Link
CN (1) CN1127652A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1062176C (en) * 1997-08-13 2001-02-21 黄付堂 Oral liquid for curing cancer
CN1114443C (en) * 1999-10-29 2003-07-16 中国科学院上海细胞生物学研究所 Medicine for induction-differential therapy and its application

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1062176C (en) * 1997-08-13 2001-02-21 黄付堂 Oral liquid for curing cancer
CN1114443C (en) * 1999-10-29 2003-07-16 中国科学院上海细胞生物学研究所 Medicine for induction-differential therapy and its application

Similar Documents

Publication Publication Date Title
CN100342891C (en) Medicine composition for hypertension and its preparation thereof
CN102772671B (en) Traditional Chinese medicine composition for treating deficiency of both qi and yin of sicca syndrome
CN101199748A (en) Chinese medicine preparation for treating hematonosis
CN1513483A (en) Oral liquid for tonifying-kidney and qi contg. eighteen herb medicines, and prepn. method thereof
CN104055909A (en) Application of compound donkey-hide gelatin pulp in preparation of medicament for menstrual period health care
CN1127652A (en) Oral liquid for restoration of cancer
CN115212284A (en) Chinese medicinal compound for treating ischemic stroke and preparation method thereof
CN1682837A (en) Medicine for regulating blood fat and its preparing method
CN103028084A (en) Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation method
CN102145099A (en) Traditional Chinese medicine for treating infertility caused by liver stagnation
CN101890068B (en) Injection for treating fracture and preparation method thereof
CN101549057A (en) Chinese medicine composition for curing hyperlipemia, cerebral arteriosclerosis and ischemic apoplexy and method of preparing the same
CN1041278C (en) Heledan capsule and making method
CN111000959B (en) Chinese patent medicine for treating spleen deficiency syndrome postoperative fatigue syndrome and preparation method thereof
CN100333785C (en) Preparation for eliminating thrombus and promoting lactation, and its preparation method
CN1097330A (en) Resina Draconis oral liquid and preparation method thereof
CN1216618C (en) A TCM compound recipe notoginseng capsule and method for preparing the same
CN109620911B (en) Traditional Chinese medicine composition capable of improving neutropenia after chemotherapy and application thereof
CN101284044B (en) Chinese medicinal composition for treating ischemic necrosis of femoral head and its preparation method
CN1170565C (en) Cancer treating astringent medicine decoction
CN107281212B (en) A kind of jujube complex polysaccharide composition and its preparation method and application
CN102225132A (en) Traditional Chinese medicine compound for treating hyperlipidaemia, cerebral arteriosclerosis and ischemic stroke and preparation method thereof
CN1050759C (en) Medicinal composite for hysteromyoma and preparing method
CN1943677A (en) A Chinese traditional medicinal composition and its preparation method
CN1063074C (en) Chinese herbs injection for treating oncoma (cancer) and preparation method

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication